Vol. XVIII · Free shipping $75+ · Read the collection
Login Register
Feature · Product Review
foxo4 dri peptide senolytic mouse study 2023

foxo4 dri peptide senolytic mouse study 2023 - an overview The disordered p53 transactivation domain

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging

SKU: 9546327291 · From tmdnewgeneration.cz

4.6
USD23.17 USD56.17

Pay in 4 interest-free payments of $5.79 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Description

N/A (complex polypeptide mixture) Pancragen Mol

foxo4 dri peptide senolytic mouse study 2023 - an overview The disordered p53 transactivation domain

KLOW BPC-157/TB-500/GHK-Cu/KPV $215.00 Original price was: $215.00.$195.00Current price is: $195.00

foxo4 dri peptide senolytic mouse study 2023 - an overview The disordered p53 transactivation domain

10.1124/mol.62.6.1464

foxo4 dri peptide senolytic mouse study 2023 - an overview The disordered p53 transactivation domain

After reconstitution, store at 2-8C and use promptly

foxo4 dri peptide senolytic mouse study 2023 - an overview The disordered p53 transactivation domain
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products